(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology >  Ethical Pharmaceuticals
 
 Ethical Pharmaceuticals Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  Next »
Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)

The considerable revenue growth in the vaccine market over the past ten years suggests the amount of vaccine production and the techniques of vaccine production will need to adapt to match a revived industry.

This report, Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts) examines the market for vaccine manufacturing and production technologies....

 

$2500.00
       
Global Lung Cancer Therapeutics Market 2012-2016

TechNavio's analysts forecast the Global Lung Cancer Therapeutics market to grow at a CAGR of 13.26 percent over the period 2012-2016....

 

$2500.00
       
Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013

“Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013"" provides data on the Cytomegalovirus (HHV-5) Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections....

 

$2500.00
       
Global Parkinson's Disease Market 2012-2016

Global Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Parkinson's Disease market landscape and its growth prospects in the coming years....

 

$2500.00
       
The 2011 Global Pharmaceutical Market Dynamics and Trends Through 2016

A 25-page worldwide strategic overview of the pharmaceutical market, including:
  • Sales forecast for major product segments: ethical, OTC, generics.
  • Sales forecast for key geographic regions: North America, Europe, Japan, Latin America....

 

$2450.00
       
Lung Cancer Vaccines and Therapeutic Antibodies

This report provides a comprehensive review of 27 candidate therapeutic antibodies and 42 candidate vaccines that are being evaluated for the treatment of lung cancer, covering pipeline, disease-targeting strategies and clinical findings. These antibodies are directed at 17 targets, while the vaccines are directed at 24 antigens or antigen combinations.

 

$2290.00
       
Lymphoma Drug Pipeline Update 2012

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system.

There are today 211 companies plus partners developing 302 lymphoma drugs in 415 developmental projects in cancer....

 

$2249.00
       
Leukemia Drug Pipeline Update 2012

Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 260 companies plus partners developing 333 leukemia drugs in 489 developmental projects in cancer....

 

$2249.00
       
Antibodies in Oncology Drug Pipeline Update 2012

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic antibodies. There are today 296 companies plus partners developing 560 antibody drugs in 1270 developmental projects in cancer....

 

$2249.00
       
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors

Product Description The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets:

 

$2100.00
       
Chinese Markets for Antibiotics

China's demand for Antibiotics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow....

 

$2000.00
       
Chinese Markets for OTC Drugs

China's demand for OTC Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow....

 

$2000.00
       
Diabetes - Pipeline Review, H2 2013

'Diabetes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest updates, and special features on late-stage and discontinued projects....

 

$2000.00
       
Bacterial Pneumonia - Pipeline Review, H2 2013

'Bacterial Pneumonia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Pneumonia, complete with latest updates, and special features on late-stage and discontinued projects....

 

$2000.00
       
Menopausal Disorders - Pipeline Review, H2 2013

'Menopausal Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects....

 

$2000.00
       
Spinal Cord Disorders - Pipeline Review, H2 2013

'Spinal Cord Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Spinal Cord Disorders, complete with latest updates, and special features on late-stage and discontinued projects....

 

$2000.00
       
AstraZeneca: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market

A strategic assessment of AstraZeneca, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.

Contains 97 pages and 8 tables



 

$1900.00
       
Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market

A strategic assessment of Bristol-Myers Squibb, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.

Contains 88 pages and 20 tables



 

$1900.00
       
« Previous     1  2  3  4  5  6  7  8   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X